Atomwise

Series-B+
atomwise.com Biotech & Healthcare Founded 2012
Total Funding $171M
Latest Round Undisclosed Series-B+
Last Announced Mar 18, 2025
Investors Undisclosed
Decision Makers 5 Verified

About Atomwise

Atomwise uses a machine learning platform to discover novel, drug-like molecules. Its programs deliver potential in immune and inflammatory diseases. Atomwise offers a machine learning-based drug discovery service.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Year Founded 2012
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website atomwise.com
Domain Registered Date Dec 17, 2012

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

6 Events
  1. Capital Raise

    Series-B+ announced

    startupintros.com

  2. Capital Raise

    Raised $120,000,000 · Series-B+

    startupintros.com

  3. Capital Raise

    Raised $45,000,000 · Series-A

    startupintros.com

  4. Capital Raise

    Raised $6,000,000 · Seed

    startupintros.com

  5. Milestone

    Website domain registered

    atomwise.com

  6. Milestone

    Company founded

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Atomwise.

Funding History

4 Rounds
Series-B+ · Mar 18, 2025
Series-B+ · Aug 1, 2020
$120,000,000 startupintros.com
Series-A · Mar 1, 2018
Seed · Jun 1, 2015

Founders & Leadership

1

Abraham Heifets

Co-Founder and CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts